Myeloid Cell-Specific Deletion of PDGFR-α Promotes Dysbiotic Intestinal Microbiota and thus Increased Colitis Susceptibility
Journal of Crohn's and Colitis · 2023
DOI: 10.1093/ecco-jcc/jjad103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Crohn's and Colitis, 2023. Verfasst von Ronja Dörk und 9 weiteren Autor:innen. Beteiligte Einrichtung: I. Department of Medicine, University Medical Center, Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background and Aims The incidence of inflammatory bowel diseases [IBD] is steadily increasing, and thus the identification of new targets to improve therapy is a major goal. Growth factors of the PDGF family and their receptors are expressed early in intestinal development and are found in mononuclear cells and macrophages in adult tissues. Macrophages play a distinct role in the pathogenesis of IBD since their function is crucial to maintaining tolerance.
Methods
We aimed to study the role of myeloid expression of PDGFR-α in mediating intestinal homeostasis in mouse IBD and infectious models.
Results
Our results show that loss of myeloid PDGFR-α increases susceptibility to dextran saline sulphate-induced colitis. Accordingly, LysM-PDGFR-α-/- mice showed higher colitis scores, and reduced levels of anti-inflammatory macrophages compared to control mice. This effect was mediated via a pro-colitogenic microbiota, which developed in the absence of myeloid PDGFR-α and caused increased colitis susceptibility in gnotobiotic mice upon faecal microbiota transplantation compared to controls. Furthermore, LysM-PDGFR-α-/- mice had a leaky gut, accompanied by impaired phagocytosis, resulting in a severe barrier defect.
Conclusions
Taken together, our results indicate a protective role for myeloid PDGFR-α in maintaining gut homeostasis by promoting a protective intestinal microbiota and providing an anti-inflammatory macrophage phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- I. Department of Medicine, University Medical Center, Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.
- GIM, Pferdebachstr. 29, 58455 Witten, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Dörk, R., Pelczar, P., Shiri, A. M., Volmari, A., Zierz, E., Giannou, A., Böttcher, M., Bosurgi, L., Huber, S., & Manthey, C. F. (2023). Myeloid Cell-Specific Deletion of PDGFR-α Promotes Dysbiotic Intestinal Microbiota and thus Increased Colitis Susceptibility. Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjad103
Vancouver
Dörk R, Pelczar P, Shiri AM, Volmari A, Zierz E, Giannou A, et al. Myeloid Cell-Specific Deletion of PDGFR-α Promotes Dysbiotic Intestinal Microbiota and thus Increased Colitis Susceptibility. Journal of Crohn's and Colitis. 2023. doi:10.1093/ecco-jcc/jjad103
BibTeX
@article{Drk2023,
author = {Dörk, Ronja and Pelczar, Penelope and Shiri, Ahmad M and Volmari, Annika and Zierz, Elisabeth and Giannou, Anastasios and Böttcher, Marius and Bosurgi, Lidia and Huber, Samuel and Manthey, Carolin F},
title = {Myeloid Cell-Specific Deletion of PDGFR-α Promotes Dysbiotic Intestinal Microbiota and thus Increased Colitis Susceptibility},
journal = {Journal of Crohn's and Colitis},
year = {2023},
doi = {10.1093/ecco-jcc/jjad103}
}
EUVIMED